Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization

Pancreatic cancer rapidly acquires resistance to chemotherapy resulting in its being difficult to treat. Gemcitabine is the current clinical chemotherapy strategy; however, owing to gemcitabine resistance, it is only able to prolong the life of patients with pancreatic cancer for a limited number of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Yan, Tao, Li, Hai-Ying, Wu, Jian-Song, Niu, Qiang, Duan, Wei-Hong, Han, Qing-Zeng, Ji, Wang-Ming, Zhang, Tao, Lv, Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2017
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652142/
https://ncbi.nlm.nih.gov/pubmed/29098031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6836
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller